Our findings indicate that a higher mutation probability of TP53, coupled with a lower mutation probability of CTNNB1, is prevalent in high-risk groups, strongly suggesting that HCC classified within the TP-TME high-risk subtype is more aggressive. This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.